Results of a 2022 study using the IQVIA LRx database for the United Kingdom (UK) and Germany were similar to those of this study, with 66% to 72% and 71% to 81% of incident and prevalent users, respectively, receiving dulaglutide 1.5 mg post-index [13]
Whilst tirzepatide typically improves lipid profiles, comprehensive cardiovascular risk management remains essential for patients with type 2 diabetes or obesity
Semaglutide carries important safety considerations that require careful patient selection and ongoing monitoring
We believe everyone deserves access to the most effective weight management tools available, delivered in the safest way possible
10.1073/pnas.1204176109 323 YeonA.YouS.KimM.GuptaA.ParkM
Instead, its the side effects of these medications that can create an environment in your mouth thats highly conducive to dental problems